-
5
-
-
0015694748
-
A new consistent abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and giemsa staining
-
(1973)
Nature
, vol.243
, pp. 290-293
-
-
Rowley, J.D.1
-
6
-
-
0029995607
-
The molecular biology of chronic myeloid leukemia
-
(1996)
Leukemic
, vol.10
, pp. 751-756
-
-
Melo, J.V.1
-
9
-
-
0034670036
-
The molecular biology of chronic myeloid leukemia
-
(2000)
Blood
, vol.96
, pp. 3343-3356
-
-
Deininger, M.W.1
-
10
-
-
0025117392
-
Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome
-
(1990)
Science
, vol.247
, Issue.4944
, pp. 824-830
-
-
Daley, G.Q.1
-
14
-
-
0029947186
-
Effects of a selective inhibitor of the ABL tyrosine kinase on the growth of BCR-ABL positive cells
-
(1996)
Nature Med.
, vol.2
, pp. 561-566
-
-
Druker, B.J.1
-
15
-
-
0030853063
-
The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells
-
(1997)
Blood
, vol.90
, pp. 3691-3698
-
-
Deininger, M.W.1
-
18
-
-
0035810147
-
Efficacy and safety of a specific inhibitor of the Bcr-Abl tyrosine kinase in chronic myeloid leukemia
-
(2001)
New Engl. J. Med.
, vol.344
, pp. 1031-1037
-
-
Druker, B.J.1
-
19
-
-
0035810142
-
Activity of a specific inhibitor of the Bcr-Abl tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
-
(2001)
New Engl. J. Med.
, vol.344
, pp. 1038-1042
-
-
Druker, B.J.1
-
20
-
-
0001338423
-
Phase II study of STI571, a tyrosine kinase inhibitor, in patients with resistant or refractory Philadelphia chromosome positive chronic myeloid leukemia
-
(2000)
Blood
, vol.96
-
-
Kantarjian, H.1
-
21
-
-
0000869570
-
A Phase II study to determine the safety and anti-leukemic effects of STI571 in patients with Philadelphia chromosome positive chronic myeloid leukemia in myeloid blast crisis
-
(2000)
Blood
, vol.96
-
-
Sawyers, C.L.1
-
22
-
-
0001566710
-
A Phase II study of STIS71 in adult patients with Philadelphia chromosome positive chronic myeloid leukemia in accelerated phase
-
(2000)
Blood
, vol.96
-
-
Talpaz, M.1
-
23
-
-
0035800507
-
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
-
(2001)
Science
, vol.293
, pp. 876-880
-
-
Gorre, M.E.1
-
24
-
-
0035929673
-
Roots of clinical resistance to STI-571 cancer therapy
-
(2001)
Science
, vol.293
, pp. 2163
-
-
Hochhaus, A.1
-
25
-
-
0035929652
-
Roots of clinical resistance to STI-571 cancer therapy
-
(2001)
Science
, vol.293
, pp. 2163
-
-
Barthe, C.1
-
26
-
-
15644363454
-
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
-
(1998)
Science
, vol.279
, pp. 577-580
-
-
Hirota, S.1
-
27
-
-
0033883060
-
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors
-
(2000)
Am. J. Pathol.
, vol.156
, pp. 791-795
-
-
Lux, M.L.1
-
28
-
-
0000244046
-
Evaluation of the safety and efficacy of an oral molecularly-targeted therapy, STI571, in patients with unresectable or metastatic gastrointestinal stromal tumors (GISTS) expressing c-KIT (CD117)
-
(2001)
Proc. Am. Soc. Clin. Oncol.
, vol.20
-
-
Blanke, C.D.1
-
30
-
-
0033883653
-
The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 3319-3326
-
-
Krystal, G.W.1
-
31
-
-
0034691761
-
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI571
-
(2000)
Oncogene
, vol.19
, pp. 3521-3528
-
-
Wang, W.L.1
-
32
-
-
85112384821
-
STI571 inhibits the kinase activity of wild type and juxtamembrane c-kit mutants but not the exon 17 D816V mutation associated with mastocytosis
-
(2000)
Blood
, vol.96
-
-
Heinrich, M.C.1
-
33
-
-
0028224348
-
Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5; 12) chromosomal translocation
-
(1994)
Cell
, vol.77
, pp. 307-316
-
-
Golub, T.R.1
-
34
-
-
0031454003
-
CGP57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL and TEL-PDGFR fusion proteins
-
(1997)
Blood
, vol.90
, pp. 4947-4952
-
-
Carroll, M.1
-
35
-
-
0003286050
-
Chronic myeloproliferative diseases with t(5; 12) and a PDGFRB fusion gene: Complete cytogenetic remissions on STI571
-
(2001)
Blood
, vol.98
-
-
Apperley, J.F.1
-
36
-
-
0034665138
-
Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class
-
(2000)
Cancer Res.
, vol.60
, pp. 5143-5150
-
-
Kilic, T.1
|